Next Article in Journal
Hajdu-Cheney Syndrome: A Novel NOTCH2 Mutation in a Spanish Child in Treatment with Vibrotherapy: A Case Report
Next Article in Special Issue
Comorbidity Patterns in Patients with Atopic Dermatitis Using Network Analysis in the EpiChron Study
Previous Article in Journal
Fractional Carbon Dioxide Laser Improves Vaginal Laxity via Remodeling of Vaginal Tissues in Asian Women
Previous Article in Special Issue
New and Upcoming Topical Treatments for Atopic Dermatitis: A Review of the Literature
 
 
Article
Peer-Review Record

National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis

J. Clin. Med. 2022, 11(17), 5204; https://doi.org/10.3390/jcm11175204
by Niccolò Gori 1,2, Andrea Chiricozzi 1,2,*, Franco Marsili 3, Silvia Mariel Ferrucci 4, Paolo Amerio 5, Vincenzo Battarra 6, Salvatore Campitiello 7, Antonio Castelli 8, Maurizio Congedo 9, Monica Corazza 10, Antonio Cristaudo 11, Gabriella Fabbrocini 12, Giampiero Girolomoni 13, Giovanna Malara 14, Giuseppe Micali 15, Giovanni Palazzo 16, Aurora Parodi 17, Annalisa Patrizi 18, Giovanni Pellacani 19, Paolo Pigatto 20, Eugenio Provenzano 21, Pietro Quaglino 22, Marco Romanelli 23, Mariateresa Rossi 24, Paola Savoia 25 and Ketty Peris 1,2add Show full author list remove Hide full author list
Reviewer 1:
Reviewer 2:
J. Clin. Med. 2022, 11(17), 5204; https://doi.org/10.3390/jcm11175204
Submission received: 18 July 2022 / Revised: 21 August 2022 / Accepted: 27 August 2022 / Published: 2 September 2022
(This article belongs to the Special Issue Atopic Dermatitis: Research and Clinical Updates and Perspectives)

Round 1

Reviewer 1 Report

Current study by Gori et al underlines the utility of organizing information campaigns on atopic dermatitis to enhance awareness regarding disease features and management, which facilitate early diagnosis with subsequent reduction of the burden of disease. It is a well written article. I have few comments:

 A separate section should be mentioned for biomarkers that have been described before for  general clinical use for diagnosis of atopic dermatitis e.g. serum levels of CD30, IgE levels, Macrophage-Derived Chemoattractant (MDC), interleukins (IL)-12

 

 In clinical trials, the most commonly used AD-specific, dermatology-specific, and generic scale for children’s should be mentioned

 

 Future perspectives for further development and evaluation of practical clinical quality of life scales for AD should be discussed.

 

 Association of AD with other disease or disorders e.g. cancer, obesity, and its impact on person’s sleep or behavior should be mentioned .

 

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

The Manuscript jcm-1846954-peer-review-v1

Manuscript jcm-1846954-peer-review-v1 describes the importance of national information campaign to reveal disease characteristics and burden in adult patients suffering from atopic dermatitis.

The manuscript has important findings that could be of interest to the readers of Journal of Clinical Medicine. However, the following comments need to be addressed before publication.    

 

Major concerns:

1.       Title: the study was designed to elucidate the characteristics AD in adult patients. It is important to amend the title to include “adult patients”.

2.       Abstract, lines 64-66: the sentence “Almost one third of patients ……..  were treated with a systemic treatment” is confusing. It might be clearer to describe the percentage of patients who were treated by topical, systematic, and both topical and systematic, as well as the untreated patients. 

3.       Abstract, lines 68-70: the sentence “This study shows a profound unmet need in AD,” is vague. The authors need to be more specific and describe the main findings followed by a conclusion.

4.       Keywords, line 72: the word “open-day” seems unrelated to the topic of the manuscript. It is recommended to avoid.

5.       Materials and methods: it is unclear if the authors have obtained ethical approval to conduct the study.

6.       Materials and methods: the inclusion and the exclusion criteria were not described.

7.       Materials and methods, line 126: Although it was described in the results section, it is recommended to describe professions that were highlighted by white and blue collars in the materials and method section as it first appears in the manuscript.

 

Minor concerns:

1.       Abstract, line 61: the following sentence “resulted affected” should read “affected”.

2.       Abstract, lines 63-64: the abbreviated phrases must be mentioned in full as they first appear in the abstract.

3.       Introduction, line 99: “of AD it might be” should read “of AD, it might be”.

4.       Results, line 159: “manifestations resulted of” should read “manifestations was”.

 

5.       Results, line 190: “37.5% 134/357” should read “37.5% (134/357)”.

Author Response

Dear Reviewer,

thank you for your suggestions.

Below is the list of answers to your questions point by point.

 

Question 1

Title: the study was designed to elucidate the characteristics AD in adult patients. It is important to amend the title to include “adult patients”.

Answer 1

I included the term "adult patients" in the title

Question 2

Abstract, lines 64-66: the sentence “Almost one third of patients ……..  were treated with a systemic treatment” is confusing. It might be clearer to describe the percentage of patients who were treated by topical, systematic, and both topical and systematic, as well as the untreated patients. 

Answer 2

I described in the abstract the percentage of patients for each type of treatments

Question 3

Abstract, lines 68-70: the sentence “This study shows a profound unmet need in AD,” is vague. The authors need to be more specific and describe the main findings followed by a conclusion.

Answer 3

I described the main findings of the study at the end of the abstract 

Question 4

Keywords, line 72: the word “open-day” seems unrelated to the topic of the manuscript. It is recommended to avoid.

Answer 4

I replaced the term Open-day with information campaign

Question 5

Materials and methods: it is unclear if the authors have obtained ethical approval to conduct the study.

Answer 5

As a screening program, it was not necessary to apply for ethics committee approval, because patients didn’t furnish any sensitive data to the centers.

I added this phrase in the text (127-129)

Question 6

Materials and methods: the inclusion and the exclusion criteria were not described.

Answer 6

I added inclusion criteria in Materials and methods (line 130-131)

Question 7

Materials and methods, line 126: Although it was described in the results section, it is recommended to describe professions that were highlighted by white and blue collars in the materials and method section as it first appears in the manuscript.

Answer 7

I described in materials and methods the professions that were highlighted by white and blue collars (line 137-140)

I followed all suggestions contained in minor concerns.

 

Author Response File: Author Response.pdf

Back to TopTop